DXCM
$84.89
Revenue | $1036Mn |
Net Profits | $105.4Mn |
Net Profit Margins | 10.17% |
PE Ratio | 62.51 |
Dexcom, Inc.’s revenue jumped 12.49% since last year same period to $1036Mn in the Q1 2025. On a quarterly growth basis, Dexcom, Inc. has generated -6.96% fall in its revenue since last 3-months.
Dexcom, Inc.’s net profit fell -28.01% since last year same period to $105.4Mn in the Q1 2025. On a quarterly growth basis, Dexcom, Inc. has generated -30.52% fall in its net profits since last 3-months.
Dexcom, Inc.’s net profit margin fell -36% since last year same period to 10.17% in the Q1 2025. On a quarterly growth basis, Dexcom, Inc. has generated -25.32% fall in its net profit margins since last 3-months.
Dexcom, Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 62.51.
EPS Estimate Current Quarter | 0.57 |
EPS Estimate Current Year | 0.57 |
Dexcom, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.57 - a 27.79% jump from last quarter’s estimates.
Dexcom, Inc.’s earning per share (EPS) estimates for the current year stand at 0.57.
Earning Per Share (EPS) | 0 |
Dexcom, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Dexcom, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-01 | 0.33 | 0.32 | -2.56% |
2025-10-23 | 0.57 | 0 | -100% |